# Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection

> **NCT02140450** · NA · COMPLETED · sponsor: **Mashhad University of Medical Sciences** · enrollment: 70 (actual)

## Conditions studied

- Intraocular Pressure Change in Intravitreal Injection

## Interventions

- **DRUG:** Timolol
- **DRUG:** Brimonidine
- **DRUG:** Acetazolamide
- **DRUG:** Mannitol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02140450
- **Lead sponsor:** Mashhad University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02140450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02140450, "Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02140450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*